{"url_path":"/sec/crsp/8-k/2026-06-04/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-257593-index.html","accession_number":"0001193125-26-257593","cik":"0001674416","ticker":"CRSP","issuer_name":"CRISPR Therapeutics AG","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-257593-index.html","primary_entity_key":"0001674416","primary_entity_name":"CRISPR Therapeutics AG"},"word_count":216,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits\n\n(d) Exhibits\n\n \n\n \n\nExhibit\nNumber\n\nDescription\n\n3.1*\n\n[Amended and Restated Articles of Association of CRISPR Therapeutics AG](crsp-ex3_1.htm)\n\n10.1*\n\n \n\n[CRISPR Therapeutics AG 2026 Stock Option And Incentive Plan](crsp-ex10_1.htm)\n\n10.2*\n\n \n\n[Form of Incentive Stock Option Agreement under the CRISPR Therapeutics AG 2026 Stock Option And Incentive Plan](crsp-ex10_2.htm)\n\n10.3*\n\n \n\n[Form of Non-Qualified Stock Option Agreement for Company Employees under the CRISPR Therapeutics AG 2026 Stock Option And Incentive Plan](crsp-ex10_3.htm)\n\n10.4*\n\n \n\n[Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under the CRISPR Therapeutics AG 2026 Stock Option And Incentive Plan](crsp-ex10_4.htm)\n\n10.5*\n\n \n\n[Form of Restricted Stock Award Agreement under the CRISPR Therapeutics AG 2026 Stock Option And Incentive Plan](crsp-ex10_5.htm)\n\n10.6*\n\n \n\n[Form of Restricted Stock Unit Award Agreement for Company Employees under the CRISPR Therapeutics AG 2026 Stock Option And Incentive Plan](crsp-ex10_6.htm)\n\n10.7*\n\n \n\n[Form of Restricted Stock Unit Award Agreement for Non-Employee Directors under the CRISPR Therapeutics AG 2026 Stock Option And Incentive Plan](crsp-ex10_7.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n* Filed herewith.\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nCRISPR THERAPEUTICS AG\n\nDate: June 4, 2026\n\nBy:\n\n/s/ Samarth Kulkarni\n\nSamarth Kulkarni, Ph.D.\n\nChief Executive Officer"}